GHK-CU 50MG
GROWTH HORMONE AXIS RESEARCH
CJC-1295 + IPAMORELIN 10MG
Best Sellers, Growth Hormone Axis Research, Research Peptide Pens
One pre-filled 10mg research pen combining CJC-1295 (no DAC) 5mg and Ipamorelin 5mg.
£139.99Free UK tracked delivery
- Made fresh to order
- Batch documentation pending
- UK tracked delivery
- Order by 1pm on working days for same-day dispatch
- Results published when verified
Research Use Only
CJC-1295 + Ipamorelin 10mg is a two-peptide research blend of CJC-1295 (no DAC) and ipamorelin, supplied in one pre-filled research pen with 5 mg of each. Every pen is prepared to order in the UK and shipped cold chain by tracked delivery.
The two peptides act on different receptors in the growth hormone axis, which is why they are often studied together. Read CJC-1295 vs ipamorelin for how they compare, and peptide stacks explained for how research blends are put together. For a full-length GHRH analogue, see tesamorelin.
Blend composition
| CJC-1295 (no DAC) | 5 mg · 29-amino-acid GHRH analogue (modified GRF 1-29) |
|---|---|
| Ipamorelin | 5 mg · Synthetic pentapeptide, ghrelin-receptor agonist |
| Total | 10 mg in one pre-filled research pen |
How each component is studied
The two peptides in this blend act through different receptors in laboratory studies:
- CJC-1295 (no DAC), also called modified GRF (1-29), is the first 29 amino acids of GHRH with four amino-acid substitutions that slow its breakdown. It acts on the GHRH receptor. Most published CJC-1295 data concern the related DAC form, which binds albumin and lasts far longer; the no-DAC form supplied here does not carry that albumin-binding group.
- Ipamorelin is a synthetic pentapeptide that activates the ghrelin receptor (GHS-R1a). In pig and rat studies it released growth hormone without the rises in ACTH and cortisol seen with other secretagogues.
5 key research areas
- GHRH receptor signalling. Rat studies examined GHRH (1-29) analogues at the GHRH receptor on the anterior pituitary.
- Ghrelin receptor selectivity. Ipamorelin was characterised as a selective growth hormone secretagogue in pig and rat models.
- Pulsatile growth hormone release. Studies examined whether the natural pulse pattern of growth hormone persists during continuous GHRH receptor stimulation.
- Growth and IGF-1 models. CJC-1295 was studied in GHRH-knockout mice, a model lacking natural GHRH.
- Bone formation models. Ipamorelin was examined in adult rats given glucocorticoids, a model of reduced bone formation.
Selected published research
Peer-reviewed studies on each component, with PubMed IDs:
- Raun K, et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. PMID 9849822
- Andersen NB, et al. (2001). The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats. Growth Hormone & IGF Research. PMID 11735244
- Jetté L, et al. (2005). Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. PMID 15817669
- Teichman SL, et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology and Metabolism. PMID 16352683
- Ionescu M, Frohman LA (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology and Metabolism. PMID 17018654
- Alba M, et al. (2006). Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. American Journal of Physiology. Endocrinology and Metabolism. PMID 16822960
These references describe laboratory, animal and early clinical research on the individual compounds, and most of the CJC-1295 papers studied the DAC form. None of them studied this blend, and none makes this research material suitable for human use.
Why a single-batch blend
- Both compounds come from one batch, under one batch reference
- One Certificate of Analysis will cover the whole blend once independent testing is complete
- Fewer handling steps than preparing two separate compounds
- Consistent composition from one order to the next
What arrives
10mg blend pen
One pre-filled Apexion research pen
One pre-filled Apexion research pen
Two-compound blend
CJC-1295 (no DAC) and ipamorelin, 5 mg each
CJC-1295 (no DAC) and ipamorelin, 5 mg each
Protected packaging
Discreet and tamper-evident
Discreet and tamper-evident
Batch traceability
Batch number on every pen; independent testing in progress
Batch number on every pen; independent testing in progress
Preparation and UK dispatch
- Made fresh to order after checkout
- Prepared and quality checked before dispatch
- Tracked Royal Mail delivery across the UK
- UK-based product and documentation support
Simple, secure checkout
Pay by Bank is the preferred option
Card payments are temporarily unavailable.
Card payments are temporarily unavailable.
Independent testing is in progress; results will be published only when verified evidence is available.
Source-material testing record
The submitted source-material blend report measured 4.95 mg ipamorelin and 5.19 mg CJC-1295 (modified GRF 1-29); CJC-1295 DAC was not detected. No purity percentage was reported.
Scope: This information concerns a submitted source-material sample. It does not certify an Apexion finished pen or establish a match to the pen batch.
View source-material record (PDF) →
The original laboratory report is available on request.
Research use only. This blend is supplied for in-vitro laboratory research by qualified researchers. It is not a medicine, is not licensed by the MHRA, and is not intended for human or veterinary use, diagnosis or treatment.
| Content | 10 mg total, one pre-filled research pen |
|---|---|
| Purity | Independent testing in progress; results published on verification |
| Active ingredient | CJC-1295 (no DAC) 5 mg · Ipamorelin 5 mg |
| CAS | 863288-34-0 (CJC-1295) / 170851-70-4 (Ipamorelin) |
| Molecular formula | C152H252N44O42 / C38H49N9O5 |
| Molecular weight | ~3367.9 / ~711.9 g/mol |
| Form | Pre-filled research pen (two-peptide blend) |
| Origin | UK-stocked, tracked Royal Mail dispatch |
| Intended use | Laboratory research only. Not for human consumption. |
APEXION BIOLABS
Quality & Verification
Batch Verification Record
Independent analytical documentation for CJC-1295 + Ipamorelin 10 mg.
Verification statusSource-material report reviewed
Product & Record
| Product | CJC-1295 + Ipamorelin 10 mg |
|---|---|
| Apexion verification ID | AX-QV-CJCIPA-001 |
| Analytical laboratory | Janoshik Analytical |
| Documentation status | Original laboratory report available on request |
| Finished pen batch testing | In progress. Results will be published here once verified. |
Documented Analytical Information
| Material tested | Lyophilised source-material blend |
|---|---|
| Purity specification | No purity percentage stated (blend-content analysis) |
| Independent analysis | Analysis by Janoshik Analytical, 24 Apr 2026 |
| Ipamorelin | 4.95 mg |
| CJC-1295 (mod GRF 1-29) | 5.19 mg |
| CJC-1295 DAC | Not detected |
Verification Statement
Apexion BioLabs has summarised the supplied independent laboratory information for a source-material sample. The original report is retained separately and is not altered or re-issued as an Apexion laboratory certificate.
Documentation Transparency
Blend-content analysis. The supplied report does not state a purity percentage.
The source-material result does not certify an Apexion finished pen or establish a match to any Apexion product batch. Supplier identity and supply-chain identifiers are omitted from this customer summary; originals are available for verification.
Independent lab analysisSupporting documentationApexion verification record
Apexion BioLabs – Batch Verification RecordAX-QV-CJCIPA-001
| Documentation status | Independent source-material analysis available (Janoshik Analytical); finished-pen batch testing in progress |
|---|---|
| Test method | HPLC (purity and identity) |
| Analysis | Janoshik Analytical (independent laboratory) on a source-material sample; testing of finished pen batches is in progress |
| Verification | Apexion verification record AX-QV-CJCIPA-001; the original laboratory report is retained by Apexion and available on request |
Storage conditions
- Shipped cold chain to keep the pen cool in transit
- Long-term: −20 °C in a temperature-controlled environment
- Short-term: keep cool and stable (2–8 °C) and away from direct light
- Keep the pen sealed when not in use
- Avoid repeated temperature changes (freeze–thaw cycles)
Handling guidance
- Check that the packaging and tamper seal are intact on arrival
- Handle as little as possible, using standard laboratory practice
- Record the batch number for traceability
- Follow any batch-specific guidance supplied with your order
What is the CJC-1295 + ipamorelin blend?
It is a two-peptide research blend of CJC-1295 (no DAC) and ipamorelin, supplied as 10 mg in one pre-filled research pen. CJC-1295 acts on the GHRH receptor and ipamorelin on the ghrelin receptor. It is for laboratory research only.
What does no DAC mean?
DAC stands for drug affinity complex, a chemical group that lets CJC-1295 bind albumin and stay in circulation much longer. The no-DAC form, also called modified GRF (1-29), lacks this group. This blend contains the no-DAC form.
What ratio is used in this blend?
Each pen contains CJC-1295 (no DAC) 5 mg and ipamorelin 5 mg, for 10 mg in total. Both compounds come from one batch under one batch reference.
Is the CJC-1295 + ipamorelin blend independently tested?
Every CJC-1295 + ipamorelin pen is made fresh after your order is placed, so each one is prepared and quality checked to order rather than taken from old stock. Independent third-party testing of the blend is under way, and the batch Certificate of Analysis will be published as soon as the results are verified. Each pen carries a batch number, so its documentation can be traced.
Can the CJC-1295 + ipamorelin blend be used in humans or animals?
No. The blend is not a medicine and is not licensed by the MHRA. It is supplied strictly for in-vitro laboratory research, and is not for human or veterinary use, diagnosis or treatment.
How should the CJC-1295 + ipamorelin blend be stored?
The CJC-1295 + ipamorelin blend is shipped cold chain. On arrival, keep the pen sealed and store it at −20 °C for long-term storage, away from heat and direct light. Handle it as little as possible and follow any batch-specific guidance supplied with your order.
Upsell
Frequently bought together
Bundle price
£184.98
£199.98
Save £15.00
Cross-sell
